Published August 9, 2022 | Version V1.0

Overview of policy landscape

  • 1. Universitair Medisch Centrum Groningen

Description

The deliverable explores relevant policies in the process of reimbursement and payment of new interventions to be used in a hospital setting and identifies differences and similarities across national methodological guidelines for the conduct of Health economic evaluations (HEEs). The scope of the deliverable is narrowed to countries that take part in the clinical study of the COVend project. Furthermore, since FX06 only tends to be used in a hospital setting, the focus was on policies and regulations that apply to pharmaceuticals for inpatient use.

Files

COVend (101045956)_D7.1_Overview_of_policy_landscape.pdf

Files (664.2 kB)

Name Size
md5:0b36d361ca932a3b2344ef979f528865
664.2 kB Preview Download

Additional details

Funding

European Commission
COVend - Biomarker and AI-supported FX06 therapy to prevent progression from mild and moderate to severe stages of COVID-19 101045956